Analysis of coagulation proteins as acute-phase reactants in horses with colic

American Journal of Veterinary Research

Volumn 59, Issue 5, 1998, Pages 542-545

  Topper, Michael J ^a,b   Prasse, Keith W ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EQUIDAE;

ACUTE PHASE PROTEIN; BLOOD CLOTTING FACTOR; COMPLEMENT COMPONENT C1S INHIBITOR;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; COLIC; COMPARATIVE STUDY; ENTERITIS; HORSE; HORSE DISEASE; INTESTINE OBSTRUCTION;

ACUTE-PHASE PROTEINS; ANIMALS; BLOOD COAGULATION FACTORS; COLIC; COMPLEMENT C1 INACTIVATOR PROTEINS; HORSE DISEASES; HORSES; INFLAMMATORY BOWEL DISEASES; INTESTINAL OBSTRUCTION;

EID: 0032063719     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.1998.59.5.542     Document Type: Article

References (35)

1. Esmon CT, Taylor FB Jr, Snow TR. Inflammation and coagulation: linked processes potentially regulated through a common pathway mediated by protein C. Thromb Haemost 1991;66:160-165.
2. Pottmeyer E, Vasser MJ, Holcroft JW. Coagulation, inflammation, and response to injury. Crit Care Clin 1986;2:683-703.
3. DeLa Cadena RA, Wachtfogel YT, Colman RW. Contact activation pathway: inflammation and coagulation. In: Colman RW, Hirsh J, Marder VJ, et al, eds. Hemostasis and thrombosis: basic principles and clinical practice. 3rd ed. Philadelphia: JB Lippincott Co, 1994;219-240.
4. Nemerson Y. The tissue factor pathway of coagulation. In: Colman RW, Hirsh J, Marder VJ, et al, eds. Hemostasis and thrombosis: basic principles and clinical practice. 3rd ed. Philadelphia: JB Lippincott Co, 1994;81-93.
5. Alcaraz A, Espana F, Sanchez-Cuenca J, et al. Activation of the protein C pathway in acute sepsis. Thromb Res 1995;79:83-93.
6. Morris DD. Endotoxemia in horses. A review of cellular and humoral mediators involved in its pathogenesis. J Vet Intern Med 1991;5:167-181.
7. Hesselvick JF, Blombäck M, Brodin B, et al. Coagulation, fibrinolysis, and kallikrein systems in sepsis: relation to outcome. Crit Care Med 1989;17:724-733.
8. Harpel PC. Blood proteolytic enzyme inhibitors. Their role in modulating blood coagulation and fibrinolytic enzyme pathways. In: Colman RW, Hirsh J, Marder VJ, et al, eds. Hemostasis and thrombosis: basic principles and clinical practice. 2nd ed. Philadelphia: JB Lippincott Co, 1987;219-234.
9. Brozovic M. Physiological mechanisms in coagulation and fibrinolysis. Br Med Bull 1977;33:231-238.
10. Pepys MB. Acute phase proteins in the acute phase response. London: Springer-Verlag, 1989.
11. Laurell CB. Acute phase proteins-a group of protective proteins In: Price CP, Alberti KGMM, eds. Recent advances in clinical biochemistry. No. 3. New York: Churchill-Livingstone, 1985;103-124.
12. Dinarello CA. Interleukin-1 and the pathogenesis of the acute-phase response. N Engl J Med 1984;311:1413-1418.
13. Sheldrick R, Kent JE, Blackmore DJ. Haemoglobin binding capacity of serum as an indicator of infection in the horse. Vet Rec 1982;111:128-129.
14. Smith JE, Cipriano JE. Inflammation-induced changes in serum iron analytes and ceruloplasmin of Shetland ponies. Vet Pathol 1987;24:354-356.
15. Allen BV, Kold SE. Fibrinogen response to surgical trauma in the horse. Equine Vet J 1988;20:441-443.
16. Morris DD, Messick J, Whitlock RH, et al. Effect of equine ehrlichial colitis on the hemostatic system in ponies. Am J Vet Res 1988;49:1030-1036.
17. Pepys MB, Baltz ML, Tennent GA, et al. Serum amyloid A protein (SAA) in horses: objective measurement of the acute phase response. Equine Vet J 1989;21:106-109.
18. Takiguchi M, Fujinaga T, Naiki M, et al. Isolation, characterization, and quantitative analysis of C-reactive protein from horses. Am J Vet Res 1990;51:1215-1220.
19. Taira T, Fujinaga T, Tamura K, et al. Isolation and characterization of 1-acid glycoprotein from horses, and its evaluation as an acute-phase reactive protein in horses. Am J Vet Res 1992;53: 961-965.
20. Sandholm M, Vidovic A, Puotunen-Reinert A, et al. D-dimer improves the prognostic value of combined clinical and laboratory data in equine gastrointestinal colic. Acta Vet Scand 1995; 36:255-272.
21. Prasse KW, Topper MJ, Moore JN, et al. Analysis of hemostasis in horses with colic. J Am Vet Med Assoc 1993;203:685-693.
22. Welles EG, Prasse KW, Moore JN. Use of newly developed assays for protein C and plasminogen in horses with signs of colic. Am J Vet Res 1991;52:345-351.
23. Henry MM, Moore JN. Whole blood re-calcification time in equine colic. Equine Vet J 1991;23:303-308.
24. Topper MJ, Prasse KW. Chromogenic assays for equine coagulation factors VII, VIII:C, IX, and X, and C1-esterase inhibitor. Am J Vet Res 1998;59:xxx-xxx.
25. Welles EG Prasse KW, Duncan A. Chromogenic assay for equine plasminogen. Am J Vet Res 1990;51:1080-1085.
26. Prasse KW, Allen Jr D, Moore JN, et al. Evaluation of coagulation and fibrinolysis during the prodromal stages of carbohydrate-induced acute laminitis in horses. Am J Vet Res 1990;51:1950-1955.
27. Morris DD Recognition and management of disseminated intravascular coagulation in horses. Vet Clin North Am Equine Pract 1988;4:115-143.
28. Hesselvick JF, Blombäck M, Brodin B, et al. Coagulation, fibrinolysis, and kallikrein systems in sepsis: relation to outcome. Crit Care Med 1989;17:724-733.
29. Friberger P. Chromogenic peptide substrates: their use for assay of factors in the fibrinolytic and the plasma kallikrein-kinin systems. Scand J Clin Lab Invest 1982;42(Suppl 162):1-298.
30. Johnston IB, Crane S. Hemostatic abnormalities in equine colic. Am J Vet Res 1986;47:356-358.
31. Morris DD, Moore JN, Crowe N. Serum tumor necrosis factor activity in horses with colic attributable to gastrointestinal tract disease. Am J Vet Res 1991;52:1565-1569.
32. Cargile JL, MacKay RJ, Dankert JR, et al. Effects of tumor necrosis factor blockade on interleukin 6, lactate, thromboxane, and prostacyclin responses in Miniature Horses given endotoxin. Am J Vet Res 1995;56:1445-1450.
33. Le J, Vilcek J. Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest 1989;61:588-601.
34. Oltvai ZN, Wong ECC, Atkinson JP, et al. C1 inhibitor deficiency: molecular and immunologic basis of hereditary and acquired angioedema. Lab Invest 1991;65:381-388.
35. Colman RW, Marder VJ, Salzman EW, et al. Overview of hemostasis. In: Colman RW, Hirsh J, Marder VJ, et al, eds. Hemostasis and thrombosis: basic principles and clinical practice. 3rd ed. Philadelphia: JB Lippincott Co, 1994;3-18.